Strata Critical Medical Sees 87.4% Q1 Revenue Surge to $67.4M
Strata Critical Medical reported Q1 2026 revenue of $67.4 million, up 87.4% year-over-year, driven by a 32.4% rise in Logistics to $47.6 million and $19.8 million from its newly acquired Clinical division. GAAP net income reached $2.4 million and adjusted EBITDA soared to $6.4 million.
1. First Quarter Financial Results
Strata Critical Medical delivered Q1 2026 revenue of $67.4 million, up 87.4% year-over-year, achieving GAAP net income of $2.4 million versus a $1.6 million loss a year earlier and generating adjusted EBITDA of $6.4 million compared with $0.4 million.
2. Segment Performance
Logistics segment revenue climbed 32.4% to $47.6 million, while the Clinical division, added through the Keystone acquisition, contributed $19.8 million in its first quarter, driving a total gross profit increase of 100.2% to $14.1 million and expanding gross margin by 140 basis points to 21.0%.
3. Operational Advances
Operational improvements included opening a combined Logistics and Clinical hub in Chicago to support Midwest transplant centers, alongside generating positive operating cash flow for the first time as Passenger divestiture outflows wind down.
4. M&A Activity and Outlook
The company completed the bolt-on acquisition of Ohio Valley Perfusion Associates to expand regional perfusion services and reiterated full-year 2026 guidance, signaling confidence in its M&A pipeline and continued organic growth trajectory.